Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients | Zendy

Stephen Guy | Zendy; Adrian R Tramontana | Zendy; Leon J. Worth | Zendy; Eddie Lau | Zendy; Rodney J. Hicks | Zendy; John F. Seymour | Zendy; Karin Thursky | Zendy; Monica A. Slavin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients

Author(s) -

Stephen Guy,

Adrian R Tramontana,

Leon J. Worth,

Eddie Lau,

Rodney J. Hicks,

John F. Seymour,

Karin Thursky,

Monica A. Slavin

Publication year - 2012

Publication title -

european journal of nuclear medicine and molecular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.313

H-Index - 163

eISSN - 1619-7089

pISSN - 1619-7070

DOI - 10.1007/s00259-012-2143-7

Subject(s) - medicine , neutropenia , fever of unknown origin , febrile neutropenia , malignancy , cancer , radiology , positron emission tomography , nuclear medicine , chemotherapy

Febrile neutropenia (FNP) is a frequent complication of cancer care and evaluation often fails to identify a cause. [(18) F]FDG PET/CT has the potential to identify inflammatory and infectious foci, but its potential role as an investigation for persistent FNP has not previously been explored. The aim of this study was to prospectively evaluate the clinical utility of FDG PET/CT in patients with cancer and severe neutropenia and five or more days of persistent fever despite antibiotic therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research